EFFICACY OF TOLAZOLINE AND VATINOXAN IN REDUCING ADVERSE EFFECTS OF BUTORPHANOL–AZAPERONE–MEDETOMIDINE IMMOBILIZATION IN ROCKY MOUNTAIN ELK (CERVUS CANADENSIS)
Authors:
- 1 March 2024
- journal article
- research article
- Published by American Association of Zoo Veterinarians in Journal of Zoo and Wildlife Medicine
- Vol. 55 (1) , 136-142
Abstract
A mixture of butorphanol, azaperone, and medetomidine (BAM) is frequently used for immobilization of North American hoofstock. Common adverse effects include respiratory depression, hypoxemia, and bradycardia. In this nonblinded crossover study the efficacy of two a-2 adrenergic antagonists, tolazoline and vatinoxan, were evaluated in alleviating adverse effects of BAM in Rocky Mountain elk (Cervus canadensis). Early administration of these antagonists was hypothesized to cause an increase in heart rate, respiratory rate, partial pressure of oxygen (PaO2) and hemoglobin oxygen saturation (SpO2), as well as reduction in mean arterial blood pressure without affecting sedation levels. Eight captive adult female elk were immobilized on three separate occasions at least 14 d apart with 0.15 mg/kg butorphanol, 0.05 mg/kg azaperone, and 0.06 mg/kg medetomidine. Tolazoline (2 mg/kg IM), vatinoxan (3 mg/mg medetomidine IV) or sterile saline (2 ml IM) were administered 20 min postinduction. The BAM caused hypoxemia, bradycardia, and moderate hypertension, and because of the severe hypoxemia observed, all animals received intratracheal oxygen throughout immobilization. Heart rate, respiratory rate, rectal temperature, SpO2, PaO2, and systolic, diastolic, and mean arterial blood pressure were monitored every 5 min throughout the immobilization. Intramuscular tolazoline caused a brief but significant drop in mean arterial pressure compared with controls and a brief but nonsignificant increase in heart rate. Vatinoxan caused a significant drop in blood pressure and a brief significant increase in heart rate. Changes in respiratory rates and PaO2 were not observed with either antagonist; however, all animals received oxygen, which may have influenced this result. The depth of sedation was unchanged after administration of either drug.Keywords
This publication has 16 references indexed in Scilit:
- The impact of vatinoxan on medetomidine–ketamine–midazolam immobilization in Patagonian maras (Dolichotis patagonum)Veterinary Anaesthesia and Analgesia, 2021
- Cardiovascular effects of intravenous vatinoxan (MK-467) in medetomidine–tiletamine–zolazepam anaesthetised red deer (Cervus elaphus)Veterinary Anaesthesia and Analgesia, 2020
- Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2‐adrenoceptor antagonist MK‐467 in horsesVeterinary Anaesthesia and Analgesia, 2016
- Data Analysis2016
- Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidineVeterinary Anaesthesia and Analgesia, 2013
- Effects of different doses of L-659’066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidineVeterinary Anaesthesia and Analgesia, 2011
- The effects of increasing doses of MK‐467, a peripheral alpha2‐adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogsJournal of Veterinary Pharmacology and Therapeutics, 2010
- The effects of L‐659,066, a peripheral α2‐adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheepJournal of Veterinary Pharmacology and Therapeutics, 2010
- Evaluation of Intramuscular Butorphanol, Azaperone, and Medetomidine and Nasal Oxygen Insufflation for the Chemical Immobilization of White-tailed Deer, Odocoileus virginianusJournal of Zoo and Wildlife Medicine, 2008
- Selectivity of atipamezole, yohimbine and tolazoline for alpha‐2 adrenergic receptor subtypes: Implications for clinical reversal of alpha‐2 adrenergic receptor mediated sedation in sheepJournal of Veterinary Pharmacology and Therapeutics, 1998